New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma

The anti-epileptic drug valproic acid is also under trial as an anti-cancer agent due to its histone deacetylase (HDAC) inhibitory properties. However, the effects of valproic acid (VPA) are limited and concentrations required for exerting anti-neoplastic effects in vitro may not be reached in tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wedel, S A, Sparatore, A, Soldato, P D, Al-Batran, S-E, Atmaca, A, Juengel, E, Hudak, L, Jonas, D, Blaheta, R A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514123/
https://www.ncbi.nlm.nih.gov/pubmed/18266964
http://dx.doi.org/10.1111/j.1582-4934.2008.00271.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514123/
https://www.ncbi.nlm.nih.gov/pubmed/18266964
http://dx.doi.org/10.1111/j.1582-4934.2008.00271.x

Ejemplares similares